HRH3 and myelodysplastic syndrome: In contrast to our hypothesis, pitolisant did not correct anxiety-like behavior and enhanced freezing behavior in MECP2Tg1 mouse model of MDS, suggesting that inhibition of histamine H3 receptor signaling with pitolisant was not sufficient to correct these behaviors in MDS mice.